Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2701
DELISTED
Flushing Financial
FFIC
| $537K | ﹤0.01% |
25,281
-12,119
| -32% | -$266K |
|
2702
Columbia Sportswear
COLM
$2.93B
| $534K | ﹤0.01% |
7,473
+2,635
| +54% | +$210K |
|
2703
Herc Holdings
HRI
$5.64B
| $534K | ﹤0.01% |
5,924
+770
| +15% | +$92.5K |
|
|
TWO
2704
Two Harbors Investment
TWO
$1.26B
| $534K | ﹤0.01% |
26,810
-42,454
| -61% | -$859K |
|
2705
Farmers National Banc Corp
FMNB
$941M
| $533K | ﹤0.01% |
35,486
+2,496
| +8% | +$38.6K |
|
2706
Unilever
UL
$139B
| $533K | ﹤0.01% |
10,340
+100
| +1% | +$5.09K |
|
|
B
2707
DELISTED
Barnes Group Inc.
B
| $531K | ﹤0.01% |
17,044
-20,419
| -55% | -$711K |
|
|
SGFY
2708
DELISTED
Signify Health, Inc.
SGFY
| $530K | ﹤0.01% |
38,427
-28,253
| -42% | -$398K |
|
2709
Provident Financial Services
PFS
$3.27B
| $528K | ﹤0.01% |
23,733
-37,130
| -61% | -$830K |
|
|
TE
2710
T1 Energy
TE
$1.53B
| $527K | ﹤0.01% |
77,176
+33,113
| +75% | +$290K |
|
|
CND
2711
DELISTED
Concord Acquisition Corp.
CND
| $527K | ﹤0.01% |
52,903
| – | – |
|
2712
iShares US Medical Devices ETF
IHI
$3.34B
| $526K | ﹤0.01% |
10,430
-16,500
| -61% | -$899K |
|
2713
Mercury Systems
MRCY
$6.45B
| $525K | ﹤0.01% |
8,159
+6,350
| +351% | +$379K |
|
|
POND
2714
DELISTED
Angel Pond Holdings Corporation
POND
| $522K | ﹤0.01% |
53,177
| – | – |
|
|
BURU
2715
DELISTED
NUBURU INC
BURU
| $521K | ﹤0.01% |
263
-150
| -36% | -$297K |
|
|
VRTV
2716
DELISTED
VERITIV CORPORATION
VRTV
| $520K | ﹤0.01% |
4,793
-6,588
| -58% | -$897K |
|
2717
Kelly Services Class A
KELYA
$528M
| $518K | ﹤0.01% |
26,136
-16,936
| -39% | -$333K |
|
2718
Fate Therapeutics
FATE
$303M
| $516K | ﹤0.01% |
20,817
-581
| -3% | -$16K |
|
|
AQUA
2719
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $516K | ﹤0.01% |
15,901
-10,639
| -40% | -$405K |
|
2720
Methode Electronics
MEI
$612M
| $515K | ﹤0.01% |
13,928
-23,877
| -63% | -$1.03M |
|
2721
NextDecade
NEXT
$1.71B
| $515K | ﹤0.01% |
+115,908
| New | +$719K |
|
2722
Vivid Seats
SEAT
$88.1M
| $513K | ﹤0.01% |
+3,437
| New | +$622K |
|
|
ASAX
2723
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
| $513K | ﹤0.01% |
52,498
| – | – |
|
|
SRRA
2724
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $512K | ﹤0.01% |
9,304
-13,196
| -59% | -$692K |
|
2725
Canadian Solar
CSIQ
$1.05B
| $511K | ﹤0.01% |
16,400
-73
| -0.4% | -$2.24K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.